In India, we went through a whole decade 2010 to 2020 of below-normal market returns. Rs.100 invested in 2010 went up to only Rs.230 in 10 years in contrast Rs 100 invested in 1980 went up to Rs.700 by the end of the decade.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the